Production (Stage)
ProKidney Corp.
PROK
$0.9776
$0.190624.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.43M | -61.19M | -45.61M | -38.68M | -35.30M |
| Total Depreciation and Amortization | 5.93M | 5.43M | 5.00M | 4.52M | 4.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.68M | -74.55M | -77.27M | -84.41M | -80.86M |
| Change in Net Operating Assets | 10.88M | 3.96M | -9.69M | -3.53M | 13.31M |
| Cash from Operations | -121.30M | -126.35M | -127.56M | -122.10M | -98.72M |
| Capital Expenditure | -29.68M | -29.51M | -5.57M | -31.11M | -34.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.99M | 49.92M | -84.94M | -6.14M | -44.80M |
| Cash from Investing | -9.70M | 20.41M | -90.51M | -37.25M | -78.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -53.00K | -54.00K | -53.00K | -52.00K | -52.00K |
| Issuance of Common Stock | 144.46M | 144.46M | 144.33M | 139.86M | -- |
| Repurchase of Common Stock | -- | -- | -9.50M | -9.50M | -9.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 144.41M | 144.41M | 134.77M | 130.30M | -9.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.42M | 38.47M | -83.30M | -29.05M | -187.25M |